405 related articles for article (PubMed ID: 29331311)
1. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
[TBL] [Abstract][Full Text] [Related]
2. Validation of the GOLD 2017 and new 16 subgroups (1A-4D) classifications in predicting exacerbation and mortality in COPD patients.
Han MZ; Hsiue TR; Tsai SH; Huang TH; Liao XM; Chen CZ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3425-3433. PubMed ID: 30425472
[TBL] [Abstract][Full Text] [Related]
3. GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.
Leivseth L; Brumpton BM; Nilsen TI; Mai XM; Johnsen R; Langhammer A
Thorax; 2013 Oct; 68(10):914-21. PubMed ID: 23611880
[TBL] [Abstract][Full Text] [Related]
4. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.
Soriano JB; Lamprecht B; Ramírez AS; Martinez-Camblor P; Kaiser B; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Marin JM; Puhan MA; Sobradillo P; Lange P; Sternberg AL; Garcia-Aymerich J; Turner AM; Han MK; Langhammer A; Leivseth L; Bakke P; Johannessen A; Roche N; Sin DD
Lancet Respir Med; 2015 Jun; 3(6):443-50. PubMed ID: 25995071
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization.
Johannessen A; Nilsen RM; Storebø M; Gulsvik A; Eagan T; Bakke P
Am J Respir Crit Care Med; 2013 Jul; 188(1):51-9. PubMed ID: 23590268
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Hospitalization and Mortality in Patients with Chronic Obstructive Pulmonary Disease with the New Global Initiative for Chronic Obstructive Lung Disease 2023 Group Classification: A Prospective Cohort and a Retrospective Analysis.
Cheng W; Zhou A; Zeng Y; Lin L; Song Q; Liu C; Zhou Z; Peng Y; Yang M; Yang L; Chen Y; Cai S; Chen P
Int J Chron Obstruct Pulmon Dis; 2023; 18():2341-2352. PubMed ID: 37908629
[TBL] [Abstract][Full Text] [Related]
7. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease.
Chen CZ; Ou CY; Yu CH; Yang SC; Chang HY; Hsiue TR
J Am Geriatr Soc; 2015 Feb; 63(2):244-50. PubMed ID: 25641518
[TBL] [Abstract][Full Text] [Related]
8. Validation of the GOLD 2013 classification in predicting exacerbations and mortality in Taiwanese patients with chronic obstructive pulmonary disease.
Chen CZ; Ou CY; Hsu CH; Hsiue TR
J Formos Med Assoc; 2015 Dec; 114(12):1258-66. PubMed ID: 25676673
[TBL] [Abstract][Full Text] [Related]
9. Comparing the 2007 and 2011 GOLD Classifications as Predictors of all-Cause Mortality and Morbidity in COPD.
Brusse-Keizer M; Klatte M; Zuur-Telgen M; Koehorst-Ter Huurne K; van der Palen J; VanderValk P
COPD; 2017 Feb; 14(1):7-14. PubMed ID: 27442500
[TBL] [Abstract][Full Text] [Related]
10. The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.
Flynn RWV; MacDonald TM; Chalmers JD; Schembri S
Respir Res; 2018 Dec; 19(1):249. PubMed ID: 30541559
[TBL] [Abstract][Full Text] [Related]
11. GOLD Classifications, COPD Hospitalization, and All-Cause Mortality in Chronic Obstructive Pulmonary Disease: The HUNT Study.
Bhatta L; Leivseth L; Mai XM; Henriksen AH; Carslake D; Chen Y; Langhammer A; Brumpton BM
Int J Chron Obstruct Pulmon Dis; 2020; 15():225-233. PubMed ID: 32099347
[TBL] [Abstract][Full Text] [Related]
12. Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial.
Dusser D; Wise RA; Dahl R; Anzueto A; Carter K; Fowler A; Calverley PM
Int J Chron Obstruct Pulmon Dis; 2016; 11():133-45. PubMed ID: 26855568
[TBL] [Abstract][Full Text] [Related]
13. Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.
Durheim MT; Smith PJ; Babyak MA; Mabe SK; Martinu T; Welty-Wolf KE; Emery CF; Palmer SM; Blumenthal JA
Ann Am Thorac Soc; 2015 Mar; 12(3):349-56. PubMed ID: 25568929
[TBL] [Abstract][Full Text] [Related]
14. Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.
Mapel DW; Dalal AA; Johnson PT; Becker LK; Hunter AG
Int J Chron Obstruct Pulmon Dis; 2015; 10():1477-86. PubMed ID: 26251587
[TBL] [Abstract][Full Text] [Related]
15. Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD).
Montes de Oca M; López Varela MV; Laucho-Contreras ME; Casas A; Schiavi E; Rey A; Silva A;
Arch Bronconeumol; 2017 Mar; 53(3):98-106. PubMed ID: 27956034
[TBL] [Abstract][Full Text] [Related]
16. New disease severity classification of patients with stable chronic obstructive pulmonary disease in Shanghai.
Xie G; Zhang Y; Zhou X; ;
Chin Med J (Engl); 2014; 127(17):3046-50. PubMed ID: 25189943
[TBL] [Abstract][Full Text] [Related]
17. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of night-time dyspnoea in COPD and its implications for prognosis.
Lange P; Marott JL; Vestbo J; Nordestgaard BG
Eur Respir J; 2014 Jun; 43(6):1590-8. PubMed ID: 24488571
[TBL] [Abstract][Full Text] [Related]
19. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
Mittal R; Chhabra SK
COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
[TBL] [Abstract][Full Text] [Related]
20. Reanalysis of the Japanese experience using the combined COPD assessment of the 2011 GOLD classification.
Nishimura K; Oga T; Tsukino M; Hajiro T; Ikeda A; Jones PW
Respir Investig; 2014 Mar; 52(2):129-35. PubMed ID: 24636269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
